Drug product selection: the Florida experience revisited. | Zendy

Edwardh . Clouse | Zendy; W. C. McCormick | Zendy; Richard A. Angorn | Zendy; Carole L. Kimberlin | Zendy; Douglas D. Bradham | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Drug product selection: the Florida experience revisited.

Author(s) -

Edwardh . Clouse,

W. C. McCormick,

Richard A. Angorn,

Carole L. Kimberlin,

Douglas D. Bradham

Publication year - 1985

Publication title -

american journal of public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.284

H-Index - 264

eISSN - 1541-0048

pISSN - 0090-0036

DOI - 10.2105/ajph.75.3.283

Subject(s) - selection (genetic algorithm) , product (mathematics) , drug , product liability , medicine , business , liability , pharmacology , law , computer science , political science , mathematics , geometry , artificial intelligence

The comparison of drug product selection rates determined approximately one year and four years after passage of Florida's Drug Product Selection (DPS) Law indicates very little change in the product selection and brand interchange behaviors of Florida pharmacists. Lack of adequate guidelines from the state and the liability concerns of pharmacists appeared to limit an expected increase in the state DPS rate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research